Related references
Note: Only part of the references are listed.Ibudilast (AV-411): a new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes
Annemarie Ledeboer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation
Victor Fernandez-Duenas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Reduction of EphA4 receptor expression after spinal cord injury does not induce axonal regeneration or return of tcMMEP response
Lillian Cruz-Orengo et al.
NEUROSCIENCE LETTERS (2007)
Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs
Florence Noble et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain
Lillian Cruz-Orengo et al.
EXPERIMENTAL NEUROLOGY (2006)
Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery
Johnny D. Figueroa et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Chemorepellent axon guidance molecules in spinal cord injury
SP Niclou et al.
JOURNAL OF NEUROTRAUMA (2006)
Health problems of persons with spinal cord injury living in the Netherlands
JHA Bloemen-Vrencken et al.
DISABILITY AND REHABILITATION (2005)
Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats
EA Sribnick et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Upregulation of EphA3 receptor after spinal cord injury
M Irizarry-Ramírez et al.
JOURNAL OF NEUROTRAUMA (2005)
Real-time quantitative PCR analysis of temporal-spatial alterations in gene expression after spinal cord contusion
XF Wu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
From discovery to clinical trials: Treatment strategies for central neuropathic pain after spinal cord injury
CE Hulsebosch
CURRENT PHARMACEUTICAL DESIGN (2005)
Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and G beta gamma signaling
HY Wang et al.
NEUROSCIENCE (2005)
Over-expressed Bcl-2 cannot suppress apoptosis via the mitochondria in buprenorphine hydrochloride-treated NG108-15 cells
F Kugawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Expression of the polyubiquitin gene early in the buprenorphine hydrochloride-induced apoptosis of NG108-15 cells
F Kugawa et al.
DNA SEQUENCE (2004)
Neuroprotective properties of different anesthetics on axotomized rat retinal ganglion cells In vivo
S Ozden et al.
JOURNAL OF NEUROTRAUMA (2004)
Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals
JV Roughan et al.
LABORATORY ANIMALS (2002)
Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss
JB Carmel et al.
PHYSIOLOGICAL GENOMICS (2001)
Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury
CD Mills et al.
JOURNAL OF NEUROTRAUMA (2001)
Expression of Eph receptors in skeletal muscle and their localization at the neuromuscular junction
KO Lai et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-a
D Merkler et al.
JOURNAL OF NEUROSCIENCE (2001)
Share Paper
